Shareholding19 Aug 2026, 11:01 am
Thyrocare: Pledge on 7.94 Cr Shares Released by Catalyst Trusteeship
AI Summary
Catalyst Trusteeship Limited, acting as Debenture Trustee for API Holdings Limited debenture holders, has announced the release of a pledge on 7,94,69,696 equity shares of Thyrocare Technologies Ltd. This release follows the full repayment and redemption of the Non-Convertible Debentures. The pledge was originally created by Docon Technologies Private Limited. The release occurred on August 17, 2026, and impacts approximately 49.93% of the total diluted share capital of Thyrocare Technologies.
Key Highlights
- Catalyst Trusteeship released pledge on 7.94 crore Thyrocare shares.
- Release follows full repayment of Non-Convertible Debentures.
- Pledge was held by Docon Technologies in favor of the trustee.
- Transaction impacts nearly 49.93% of diluted share capital.
- Disclosure made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Price Impact
More from THYROCARE